1. The zinc-finger transcription factor KLF6 regulates cardiac fibrosis.
- Author
-
Li N, Xue Y, Zhu C, Chen N, Qi M, Fang M, and Huang S
- Subjects
- Animals, Mice, Humans, Male, Angiotensin II pharmacology, Myocardium metabolism, Myocardium pathology, Transforming Growth Factor beta metabolism, NF-kappa B metabolism, Cells, Cultured, Kruppel-Like Transcription Factors metabolism, Kruppel-Like Transcription Factors genetics, Heart Failure metabolism, Heart Failure pathology, Heart Failure genetics, Kruppel-Like Factor 6 metabolism, Kruppel-Like Factor 6 genetics, Fibrosis metabolism, Mice, Inbred C57BL, Fibroblasts metabolism, Myofibroblasts metabolism, Myofibroblasts pathology
- Abstract
Aims: Heart failure (HF) is one of the most devastating consequences of cardiovascular diseases. Regardless of etiology, cardiac fibrosis is present and promotes the loss of heart function in HF patients. Cardiac resident fibroblasts, in response to a host of pro-fibrogenic stimuli, trans-differentiate into myofibroblasts to mediate cardiac fibrosis, the underlying mechanism of which remains incompletely understood., Methods: Fibroblast-myofibroblast transition was induced in vitro by exposure to transforming growth factor (TGF-β). Cardiac fibrosis was induced in mice by either transverse aortic constriction (TAC) or by chronic infusion with angiotensin II (Ang II)., Results: Through bioinformatic screening, we identified Kruppel-like factor 6 (KLF6) as a transcription factor preferentially up-regulated in cardiac fibroblasts from individuals with non-ischemic cardiomyopathy (NICM) compared to the healthy donors. Further analysis showed that nuclear factor kappa B (NF-κB) bound to the KLF6 promoter and mediated KLF6 trans-activation by pro-fibrogenic stimuli. KLF6 knockdown attenuated whereas KLF6 over-expression enhanced TGF-β induced fibroblast-myofibroblast transition in vitro. More importantly, myofibroblast-specific KLF6 depletion ameliorated cardiac fibrosis and rescued heart function in mice subjected to the TAC procedure or chronic Ang II infusion., Significance: In conclusion, our data support a role for KLF6 in cardiac fibrosis., Competing Interests: Declaration of competing interest None., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF